Sort
21,281 grants matching “influenza”
Development of Fludase for Prevention of Influenza
$2,000,000Nexbio, Inc. · R44 · FY2005 · AI
Neuroimmune Mechanisms of Psychiatric Disorders
$2,000,000Cameron S. Carter · University Of California At Davis · P50 · FY2017 · MH
Infectious Diseases Clinical Research Program
$2,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2009 · AI
Genetic & Structural Basis for Virus Neutralization: Studies on Influenza H7 Virus
$2,000,000Gay Nell H Krauss · Vanderbilt University · N01 · FY2015 · AI
Neuroimmune Mechanisms of Psychiatric Disorders
$2,000,000Cameron S. Carter · University Of California At Davis · P50 · FY2016 · MH
A Randomized Study of Exclusion Criteria in a University Population
$1,999,963Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2011 · CK
Michigan-Ford Initiative to Measure Vaccine Effectiveness (MFIVE): Seasonal Influenza, COVID-19 and Respiratory Virus Vaccines
$1,999,909Emily Toth Martin · University Of Michigan At Ann Arbor · U01 · FY2022 · IP
Oklahoma Center of Biomedical Research Excellence (COBRE) in Structural Biology
$1,999,097Ann H West · University Of Oklahoma · P20 · FY2015 · GM
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7
$1,999,087Benny Chen · Duke University · N01 · FY2024 · AI
Big Omics Data Engine 2 Supercomputer
$1,998,264Patricia Kovatch · Icahn School Of Medicine At Mount Sinai · S10 · FY2019 · OD
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,997,204Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2016 · AG
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,996,220Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2025 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH
$1,994,885John Jay Treanor · University Of Rochester · N01 · FY2019 · AI
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,994,583Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2017 · AG
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,992,597Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2018 · AG
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,992,597Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2019 · AG
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$1,991,523Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR
Disordered Proteostasis as a Driver of Disease in the Aging Lung
$1,989,880Gr Scott Budinger · Northwestern University At Chicago · P01 · FY2020 · AG
NMR Investigations Of Cell Membrane Structure
$1,989,766Klaus Gawrisch · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,989,733Aaron Esser-Kahn · University Of Chicago · N01 · FY2024 · AI
The role of the intracellular complement system - the complosome - in Th1 biology
$1,986,770Claudia Kemper · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,985,712Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2016 · IP
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)
$1,984,256Scott Hensley · University Of Pennsylvania · N01 · FY2021 · AI
Clinical Proteomics
$1,983,623Joanna Hunter · Caprion Proteomics, Inc. · N01 · FY2011 · AI
Oklahoma Center of Biomedical Research Excellence (COBRE) in Structural Biology
$1,982,957Ann H West · University Of Oklahoma · P20 · FY2014 · GM